Immunochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites

Histopathology

Volumn 29, Issue 3, 1996, Pages 233-240

  Kaufmann, O ^a,b   Deidesheimer, T ^a   Muehlenberg, M ^a   Deicke, P ^a   Dietel, M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Breast carcinoma; Immunohistochemical profile; Metastatic carcinoma

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; ANTIBODY; APOD PROTEIN, HUMAN; APOLIPOPROTEIN; APOLIPOPROTEIN D; CARRIER PROTEIN; GLYCOPROTEIN; PIP PROTEIN, HUMAN;

ADENOCARCINOMA; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; BREAST TUMOR; CHEMISTRY; IMMUNOLOGY; LABORATORY DIAGNOSIS;

ADENOCARCINOMA; ANTIBODIES; APOLIPOPROTEINS; APOLIPOPROTEINS D; BREAST NEOPLASMS; CARRIER PROTEINS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE TRANSPORT PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0029658277     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.1996.tb01396.x     Document Type: Article

References (32)

1. Ang I.C, Debowski T, Michalski R. Immunolocalization of prealbumin (transthyretin) in renal cell carcinoma. Histopathology 1991: 18; 565-568.
2. Bejarano P, Baughman R, Biddinger P, Fenoglio-Preiser C, Al-Khafaji B, Miller M, Whitsett J. Immunohistochemical expression of surfactant proteins A and B (SP-A, SP-B) and TTF-1 to distinguish lung and breast carcinomas. Lab. Invest. 1995: 72; 148A (865).
3. Cameron BL, Butler JA, Rutgers J, Vargas HI, Purtell M, Sheppard B. Immunohislochemical determination of the estrogen receptor content of gastrointestinal adenocarcinomas. Am. Surg. 1992: 58; 758-760.
4. Canver CC, Memoli VA, Vanderveer PL, Dingivan CA, Mentzer RM. Sex hormone receptors in non small cell lung cancer in human beings. J. Thorac. Cardiovasc. Surg. 1994: 108; 153-157.
5. Caterotti G, Pileri S, Parravicini C, et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J. Pathol. 1993: 171; 83-98.
6. Domegala W, Lasota J, Bartkowiak J, Weber K, Osborn M. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am. J. Pathol. 1990: 136; 219-227.
7. Dorman AM, Chin D, Leader M. Specifity of colon specific antigen and colon ovarian tumor antigen. J. Clin. Pathol. 1992: 45; 932-933.
8. Fischer P, Störkel S, Haase W, Scherberich JE. Differential diagnosis of histogenetically distinct human epithelial renal tumors with a monoclonal antibody against γ-glutamyltransferase. Cancer Immunol. Immunother. 1991: 33; 382-388.
9. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1995: 1; 27-31.
10. Haglund C, Lundin J, Kuusela P, Roberts PJ. CA 242, a new tumor marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. Br. J. Cancer 1994: 70; 487-492.
11. Hainsworth JD, Greco FA. Treatment of patients with cancer of an unknown primary site. New Engl. J. Med. 1993: 329; 257-263.
12. Kojima O, Takahashi T, Kawakami S, Uehara Y, Matsui M. Localization of estrogen receptors in gastric cancer using immunohistochemical staining of monoclonal antibody. Cancer 1991: 67; 2401-2405.
13. Masood S. Estrogen receptor expression in adenocarcinoma of lung. Mod. Pathol. 1991: 4; 117A (Abstract).
14. Mazoujian G, Pinkus GS, Davis S, Haagensen DE. Immunohistochemistry of a breast gross cystic disease fluid protein (GCDFP-15): A marker of apocrine epithelium and breast carcinoma with apocrine features. Am. J. Pathol. 1983: 110; 105-112.
15. Mazouijan G, Margolis R. Immunohistochemistry of gross cysticdisease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin. Am. J. Dermatopathol. 1988: 10; 28-35.
16. Moll R, Loewe A, Laufer J, Franke W. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am. J. Pathol. 1992: 140; 427-447.
17. Monteagudo C, Merino MJ, LaPorte N, Neumann RD. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary. Hum. Pathol. 1991: 22; 368-372.
18. Muir C. Cancer of unknown primary site. Cancer 1995: 75; Suppl. 353-356.
19. Nap M, Hammarström M-L. Börmer et al. Specilicity and affinity of monoclonal antibodies against Carcinoembryonic Antigen: Cancer Res. 1992: 52; 2329-2339.
20. Norton AJ, Jordan S, Yeomans P. Brief, high-temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues. J. Pathol. 1994: 173; 371-379.
21. Ollayos CW, Riordan GP, Rushin JM. Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas, and lung. Arch. Pathol. Lab. Med. 1994: 18; 630-632.
22. Pancino G, Charpin C, Calvo F, Cuillemin MC, Roseto A. A novel monoclonal antibody (7B10) with differential Reactivity between human mammary carcinoma and normal breast. Cancer Res. 1987: 47; 4444-4452.
23. Pitz S, Moll R, Störkel S. Thoenes W. Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas, distinction of two classes of renal cell tumors. Lab. Invest. 1987: 56; 642-653.
24. Raab SS, Berg LC, Swanson PE, Wick MW. Adenocarcinoma in the lung in patients with breast cancer. Am. J. Clin. Pathol. 1992: 100; 27-35.
25. Robertson JF, Ellis IO, Bell J, Todd JH, Robins A, Elston CW, Blamey RW. Carcinoembryonic antigen immunocytochemistry in primary breast cancer. Cancer 1989: 64; 1638-1645.
26. Sheahan K, O'Brien MJ, Burk B et al. Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial neoplasms. Am. J. Clin. Pathol. 1989: 94; 157-164.
27. Targarona EM, Pons MD, Gonzalez G, Boix L, Marco V, Marco C. Is exocrine pancreatic cancer a hormone dependent tumor? A study of the existence of sex hormone receptors in normal and neoplastic pancreas. Hepatogastroenterology 1991: 38; 165-169.
28. Taylor OM, Teasdale J, Cowen PN, McMahon MJ, Benson EA. Classical oestrogen receptor is not detectable in pancreatic adenocarcinoma. Br. J. Cancer 1992: 66; 503-506.
29. Tomaszewski JE, Kornstein MJ. Sensitivity and specifity of URO antibodies in diagnostic surgical pathology. Lab. Invest. 1985: 52; 68A (Abstract).
30. Wick MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel JC, Kiang DT. Gross cystic disease fluid protein 15 as a marker for breast cancer. Immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum. Pathol 1989: 20; 281-287.
31. Yamada K, Ohkawa K, Joh K. Monoclonal antibody, MAb 12C3, is a sensitive imnumohistochemical marker of early malignant change in epithelial ovarian tumors. Am. J. Clin. Pathol. 1995: 103; 288-294.
32. Yokozaki H, Takekura N, Takanashi A, Tabuchi J, Haruta R, Tahara E. Estrogen receptors in gastric adenocarcinomas: a retrospective immunohistochemical analysis. Virchows Arch. A. Pathol. Anat. 1988: 413; 297-302.